Morihiro Mitsuya

1.1k total citations
20 papers, 882 citations indexed

About

Morihiro Mitsuya is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Morihiro Mitsuya has authored 20 papers receiving a total of 882 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 5 papers in Organic Chemistry. Recurrent topics in Morihiro Mitsuya's work include Receptor Mechanisms and Signaling (7 papers), Neuropeptides and Animal Physiology (5 papers) and Pharmacological Receptor Mechanisms and Effects (4 papers). Morihiro Mitsuya is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Neuropeptides and Animal Physiology (5 papers) and Pharmacological Receptor Mechanisms and Effects (4 papers). Morihiro Mitsuya collaborates with scholars based in Japan. Morihiro Mitsuya's co-authors include T. Nishimura, Jun‐ichi Eiki, Yasufumi Nagata, Kenji Kamata, Toshiaki Mase, Mitsuru Ohkubo, Hisashi Ohta, Gentaroh Suzuki, Yoshio Ogino and Norikazu Ohtake and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Tetrahedron.

In The Last Decade

Morihiro Mitsuya

19 papers receiving 841 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Morihiro Mitsuya Japan	14	642	343	173	142	133	20	882
Kim Masuda United States	15	621 1.0×	229 0.7×	237 1.4×	153 1.1×	133 1.0×	17	1.4k
Kim O’Neill United States	16	384 0.6×	114 0.3×	129 0.7×	114 0.8×	136 1.0×	30	1.2k
G.K.-W. Kong Australia	10	541 0.8×	147 0.4×	96 0.6×	159 1.1×	27 0.2×	13	815
Ramakrishna Seethala United States	19	629 1.0×	90 0.3×	286 1.7×	211 1.5×	279 2.1×	36	1.2k
Armand B. Cognetta United States	15	728 1.1×	171 0.5×	107 0.6×	81 0.6×	324 2.4×	15	1.2k
Jen‐Shin Song Taiwan	22	625 1.0×	96 0.3×	132 0.8×	125 0.9×	346 2.6×	58	1.4k
Dev Trivedi United States	21	686 1.1×	188 0.5×	194 1.1×	250 1.8×	196 1.5×	46	1.1k
Jun‐ichi Eiki Japan	17	791 1.2×	822 2.4×	51 0.3×	423 3.0×	125 0.9×	28	1.3k
Christopher C. Shelton United States	10	477 0.7×	120 0.3×	238 1.4×	63 0.4×	39 0.3×	12	1.2k
Marc P. Baggelaar Netherlands	16	281 0.4×	156 0.5×	160 0.9×	87 0.6×	129 1.0×	29	815

Countries citing papers authored by Morihiro Mitsuya

Since Specialization

Citations

This map shows the geographic impact of Morihiro Mitsuya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morihiro Mitsuya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morihiro Mitsuya more than expected).

Fields of papers citing papers by Morihiro Mitsuya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morihiro Mitsuya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morihiro Mitsuya. The network helps show where Morihiro Mitsuya may publish in the future.

Co-authorship network of co-authors of Morihiro Mitsuya

This figure shows the co-authorship network connecting the top 25 collaborators of Morihiro Mitsuya. A scholar is included among the top collaborators of Morihiro Mitsuya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morihiro Mitsuya. Morihiro Mitsuya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miura, Akihiro, Hiroshi Sootome, Naoya Fujita, et al.. (2021). TAS-119, a novel selective Aurora A and TRK inhibitor, exhibits antitumor efficacy in preclinical models with deregulated activation of the Myc, β-Catenin, and TRK pathways. Investigational New Drugs. 39(3). 724–735. 13 indexed citations

Hayashi, Hiroaki, Kenji F. Tanaka, Morihiro Mitsuya, et al.. (2018). THU0058 Tas8274, a highly selective janus kinase 3 inhibitor, shows potent efficacy, but does not affect host defense, in preclinical mouse models. Annals of the Rheumatic Diseases. 77. 253–253.

Satô, Yoshiyuki, T Sugimoto, Kaori Kamijo, et al.. (2009). Imidazopyridine derivatives as potent and selective Polo-like kinase (PLK) inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(16). 4673–4678. 46 indexed citations

Nakamura, Masayuki, et al.. (2009). Isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(2). 726–729. 27 indexed citations

Iino, Tomoharu, Yasuhiro Sasaki, Morihiro Mitsuya, et al.. (2009). Discovery and structure–activity relationships of a novel class of quinazoline glucokinase activators. Bioorganic & Medicinal Chemistry Letters. 19(19). 5531–5538. 33 indexed citations

Nishimura, T., Tomoharu Iino, Morihiro Mitsuya, et al.. (2009). Identification of novel and potent 2-amino benzamide derivatives as allosteric glucokinase activators. Bioorganic & Medicinal Chemistry Letters. 19(5). 1357–1360. 38 indexed citations

Mitsuya, Morihiro, Kenji Kamata, Hitomi Watanabe, et al.. (2009). Discovery of novel 3,6-disubstituted 2-pyridinecarboxamide derivatives as GK activators. Bioorganic & Medicinal Chemistry Letters. 19(10). 2718–2721. 38 indexed citations

Suzuki, Gentaroh, Hiroshi Fushiki, Masayuki Nakamura, et al.. (2007). In Vitro Pharmacological Characterization of Novel Isoxazolopyridone Derivatives as Allosteric Metabotropic Glutamate Receptor 7 Antagonists. Journal of Pharmacology and Experimental Therapeutics. 323(1). 147–156. 111 indexed citations

Mitsuya, Morihiro, et al.. (2005). Discovery of 2-Aminothiazole-4-carboxamides, a Novel Class of Muscarinic M3 Selective Antagonists, through Solution-Phase Parallel Synthesis. Chemical and Pharmaceutical Bulletin. 53(4). 437–440. 9 indexed citations

10.

Kamata, Kenji, Morihiro Mitsuya, T. Nishimura, Jun‐ichi Eiki, & Yasufumi Nagata. (2004). Structural Basis for Allosteric Regulation of the Monomeric Allosteric Enzyme Human Glucokinase. Structure. 12(3). 429–438. 399 indexed citations

11.

Hirose, Hiroyasu, Ikuo Aoki, Toshifumi Kimura, et al.. (2001). Pharmacological Properties of (2R)-N-[1-(6-Aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2- hydroxy-2-phenylacetamide: A Novel Muscarinic Antagonist with M2-Sparing Antagonistic Activity. Journal of Pharmacology and Experimental Therapeutics. 297(2). 790–797. 8 indexed citations

12.

Mitsuya, Morihiro, Yoshio Ogino, Toshifumi Kimura, et al.. (2000). Discovery of a muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors among 2-[(1S,3S)-3-sulfonylaminocyclopentyl]phenylacetamide derivatives. Bioorganic & Medicinal Chemistry. 8(4). 825–832. 17 indexed citations

13.

Mitsuya, Morihiro, Yoshio Ogino, Norikazu Ohtake, & Toshiaki Mase. (2000). Diastereoselective Synthesis of the Acid Part of a New Muscarinic M3 Receptor Antagonist. Tetrahedron. 56(51). 9901–9907. 17 indexed citations

14.

Mitsuya, Morihiro, Kensuke Kobayashi, Atsushi Satoh, et al.. (2000). A Potent, Long-Acting, Orally Active (2R)-2-[(1R)-3,3-Difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: A Novel Muscarinic M₃ Receptor Antagonist with High Selectivity for M₃ over M₂ Receptors. Journal of Medicinal Chemistry. 43(26). 5017–5029. 36 indexed citations

15.

Mitsuya, Morihiro, Toshiaki Mase, Yoshimi Tsuchiya, et al.. (1999). J-104129, a novel muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors. Bioorganic & Medicinal Chemistry. 7(11). 2555–2567. 39 indexed citations

16.

Mitsuya, Morihiro, et al.. (1999). Stereoselective synthesis of a new muscarinic M3 receptor antagonist, J-104129. Bioorganic & Medicinal Chemistry Letters. 9(14). 2037–2038. 16 indexed citations

17.

Iwasawa, Yoshikazu, Morihiro Mitsuya, Hitoshi Masaki, et al.. (1996). J-104,123, a novel and orally-active inhibitor of squalene synthase: Stereoselective synthesis and cholesterol lowering effects in dogs. Bioorganic & Medicinal Chemistry Letters. 6(4). 463–466. 15 indexed citations

18.

Iwasawa, Yoshikazu, Masahiro Hayashi, Morihiro Mitsuya, et al.. (1995). Synthesis and biological activity of J-104,118, a novel, potent inhibitor of squalene synthase. Bioorganic & Medicinal Chemistry Letters. 5(17). 1989–1994. 16 indexed citations

19.

Inouye, Yoshinobu, Kenji Tokuhisa, Morihiro Mitsuya, & Hiroshi Kakisawa. (1990). Preparation of 2-Oxabicyclo[2.2.2]oct-5-ene, 1,4-Dimethyl-2-oxabicyclo[2.2.2]oct-5-ene, and 6-Oxabicyclo[3.2.1]oct-3-ene. Bulletin of the Chemical Society of Japan. 63(8). 2444–2446. 1 indexed citations

20.

Inouye, Yoshinobu, Morihiro Mitsuya, Kenji Tokuhisa, & Hiroshi Kakisawa. (1990). Regio- and Facial-Selective Effects of Allylic Heteroatoms in 1,3-Dipolar Cycloaddition of a Nitrile Oxide. Bulletin of the Chemical Society of Japan. 63(11). 3300–3306. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact